X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1465) 1465
Publication (140) 140
Book Review (9) 9
Newspaper Article (9) 9
Book Chapter (7) 7
Book / eBook (3) 3
Data Set (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1171) 1171
index medicus (893) 893
oncology (869) 869
female (862) 862
male (736) 736
middle aged (730) 730
chemotherapy (676) 676
adult (671) 671
consolidation (623) 623
hematology (591) 591
aged (536) 536
antineoplastic combined chemotherapy protocols - therapeutic use (491) 491
cancer (489) 489
treatment outcome (434) 434
disease-free survival (327) 327
consolidation chemotherapy (323) 323
adolescent (315) 315
remission induction (268) 268
survival (264) 264
consolidation therapy (260) 260
therapy (257) 257
transplantation (242) 242
care and treatment (231) 231
prognosis (230) 230
young adult (214) 214
retrospective studies (204) 204
survival analysis (204) 204
patients (191) 191
survival rate (189) 189
combined modality therapy (188) 188
trial (187) 187
stem-cell transplantation (184) 184
radiotherapy (181) 181
neoplasm staging (180) 180
antineoplastic combined chemotherapy protocols - adverse effects (178) 178
hematology, oncology and palliative medicine (177) 177
follow-up studies (175) 175
leukemia (164) 164
medicine & public health (161) 161
aged, 80 and over (156) 156
analysis (156) 156
research (156) 156
stem cells (155) 155
acute myeloid leukemia (147) 147
risk factors (147) 147
acute myelogenous leukemia (143) 143
remission (143) 143
transplantation, autologous (135) 135
antineoplastic combined chemotherapy protocols - administration & dosage (134) 134
leukemia, myeloid, acute - drug therapy (132) 132
child (131) 131
health aspects (130) 130
recurrence (128) 128
consolidation chemotherapy - methods (124) 124
cytarabine - administration & dosage (123) 123
acute myeloid-leukemia (120) 120
clinical trials (120) 120
induction chemotherapy (120) 120
hematopoietic stem cell transplantation (117) 117
antineoplastic agents - therapeutic use (116) 116
bone-marrow-transplantation (113) 113
child, preschool (112) 112
cisplatin (112) 112
stem cell transplantation (109) 109
cytarabine (106) 106
immunology (105) 105
risk (105) 105
chemoradiotherapy (101) 101
hematopoietic stem cell transplantation - methods (98) 98
induction (98) 98
children (97) 97
lymphomas (92) 92
carboplatin (91) 91
multiple myeloma (91) 91
kaplan-meier estimate (90) 90
adults (89) 89
radiology, nuclear medicine & medical imaging (89) 89
relapse (89) 89
prospective studies (88) 88
high-dose chemotherapy (87) 87
minimal residual disease (87) 87
cyclophosphamide (86) 86
leukemia, myeloid, acute - mortality (86) 86
trans-retinoic acid (86) 86
bortezomib (85) 85
diagnosis (85) 85
infant (84) 84
ovarian cancer (84) 84
leukemia, myeloid, acute - therapy (83) 83
toxicity (83) 83
radiation (82) 82
randomized-trial (82) 82
aml (81) 81
patient outcomes (81) 81
cyclophosphamide - administration & dosage (79) 79
cisplatin - administration & dosage (77) 77
hematopoietic stem cells (77) 77
drug therapy (75) 75
medical research (75) 75
radiation therapy (75) 75
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1454) 1454
German (5) 5
Korean (5) 5
Russian (5) 5
French (4) 4
Chinese (3) 3
Spanish (3) 3
Polish (2) 2
Hungarian (1) 1
Japanese (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 31, pp. 3889 - +
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1853 - 1862
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined.... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | METAANALYSIS | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | INDUCTION | MARROW TRANSPLANTATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2014, Volume 61, Issue 1, pp. 95 - 101
Journal Article
BMC Cancer, ISSN 1471-2407, 10/2015, Volume 15, Issue 1, p. 767
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 3, pp. 219 - 228
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. 1153 - 1160
Purpose Systemic failure remains the major challenge in management of locally advanced rectal cancer (LARC). To optimize the timing of neoadjuvant treatment... 
Radiology | Hematology, Oncology and Palliative Medicine | SURGERY | 1ST-LINE TREATMENT | MULTICENTER | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | FLUOROPYRIMIDINE | CHEMORADIATION | CHEMORADIOTHERAPY | FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TOTAL MESORECTAL EXCISION | CHEMOTHERAPY | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Consolidation Chemotherapy - methods | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Feasibility Studies | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Fluorouracil - analogs & derivatives | Rectal Neoplasms - surgery | Deoxycytidine - administration & dosage | Induction Chemotherapy - methods | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Induction Chemotherapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - adverse effects | Neoadjuvant Therapy - methods | Aged | Consolidation Chemotherapy - adverse effects | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Sects | Chemotherapy | Capecitabine | Colorectal cancer | Radiation | Clinical trials | Product development | Radiotherapy | Sandwiches | Medical imaging equipment | Cancer | MORTALITY | PATIENTS | NEOPLASMS | CLINICAL TRIALS | RECTUM | METASTASES | TOXICITY | PATENTS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BLOOD COUNT
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1570 - 1580
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 84, Issue 2, pp. 456 - 463
Purpose To evaluate mediastinal nodal clearance (MNC) rates after induction chemotherapy and concurrent, full-dose radiation therapy (RT) in a phase II... 
Radiology | Hematology, Oncology and Palliative Medicine | SURVIVAL | SURGERY | CISPLATIN | ONCOLOGY | STAGE | RADIOTHERAPY | PULMONARY RESECTION | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Nodes - pathology | Prospective Studies | Consolidation Chemotherapy - methods | Lung Neoplasms - mortality | Mediastinum | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Neoplasm Staging - methods | Neoadjuvant Therapy - mortality | Carcinoma, Non-Small-Cell Lung - secondary | Adult | Female | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Carboplatin - administration & dosage | Lung Neoplasms - therapy | Lymphatic Metastasis | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Carcinoma, Non-Small-Cell Lung - therapy | Pneumonectomy - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Neoadjuvant Therapy - methods | Aged | Preoperative Care - methods | Care and treatment | Chemotherapy | Nuclear radiation | Surgery | Clinical trials | Lung cancer, Non-small cell | Radiotherapy | Cancer | Index Medicus | Toxicity | Mortality | Radiation | Non-small cell lung carcinoma | Oncology | Lung carcinoma | Survival | Morbidity | Paclitaxel | Carboplatin | Tumors | MORTALITY | PATIENTS | DISEASE INCIDENCE | MEDIASTINUM | LUNGS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | CHEMOTHERAPY
Journal Article
Journal Article